Scisparc ltd. regains compliance with nasdaq minimum bid price notification

Tel aviv, oct. 16, 2023 (globe newswire) -- scisparc ltd. (nasdaq: sprc), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “company”), reported the receipt of a formal notification from the nasdaq stock market llc (“nasdaq”) that the company has regained compliance with listing rule 5550(a)(2), which requires the company's ordinary shares to maintain a minimum bid price of $1.00 per share.
SPRC Ratings Summary
SPRC Quant Ranking